b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">31582544</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>11</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1592-8721</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>105</Volume>\n                    <Issue>7</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Jul</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Haematologica</Title>\n                <ISOAbbreviation>Haematologica</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1925-1936</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3324/haematol.2019.221077</ELocationID>\n            <Abstract>\n                <AbstractText>Multiple myeloma is still incurable due to an intrinsic aggressiveness or, more frequently, to the interactions of malignant plasma cells with the bone marrow (BM) microenvironment. Myeloma cells educate BM cells to support neoplastic cell growth, survival, acquisition of drug resistance resulting in disease relapse. Myeloma microenvironment is characterized by Notch signaling hyperactivation due to the increased expression of Notch1 and 2 and the ligands Jagged1 and 2 in tumor cells. Notch activation influences myeloma cell biology and promotes the reprogramming of BM stromal cells. In this work we demonstrate, <i>in vitro, ex vivo</i> and by using a zebrafish multiple myeloma model, that Jagged inhibition causes a decrease in both myeloma-intrinsic and stromal cell-induced resistance to currently used drugs, i.e. bortezomib, lenalidomide and melphalan. The molecular mechanism of drug resistance involves the chemokine system CXCR4/SDF1\xce\xb1. Myeloma cell-derived Jagged ligands trigger Notch activity in BM stromal cells. These, in turn, secrete higher levels of SDF1\xce\xb1 in the BM microenvironment increasing CXCR4 activation in myeloma cells, which is further potentiated by the concomitant increased expression of this receptor induced by Notch activation. Consistently with the augmented pharmacological resistance, SDF1\xce\xb1 boosts the expression of BCL2, Survivin and ABCC1. These results indicate that a Jagged-tailored approach may contribute to disrupting the pharmacological resistance due to intrinsic myeloma cell features or to the pathological interplay with BM stromal cells and, conceivably, improve patients\' response to standard-of-care therapies.</AbstractText>\n                <CopyrightInformation>Copyright\xc2\xa9 2020 Ferrata Storti Foundation.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Colombo</LastName>\n                    <ForeName>Michela</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Garavelli</LastName>\n                    <ForeName>Silvia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mazzola</LastName>\n                    <ForeName>Mara</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Biotechnology and Translational Medicine, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Platonova</LastName>\n                    <ForeName>Natalia</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Giannandrea</LastName>\n                    <ForeName>Domenica</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Colella</LastName>\n                    <ForeName>Raffaella</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Apicella</LastName>\n                    <ForeName>Luana</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lancellotti</LastName>\n                    <ForeName>Marialuigia</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lesma</LastName>\n                    <ForeName>Elena</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ancona</LastName>\n                    <ForeName>Silvia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Palano</LastName>\n                    <ForeName>Maria Teresa</ForeName>\n                    <Initials>MT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Barbieri</LastName>\n                    <ForeName>Marzia</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Hematology, Fondazione IRCCS C\xc3\xa0 Granda, Ospedale Maggiore Policlinico, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Taiana</LastName>\n                    <ForeName>Elisa</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Hematology, Fondazione IRCCS C\xc3\xa0 Granda, Ospedale Maggiore Policlinico, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lazzari</LastName>\n                    <ForeName>Elisa</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Basile</LastName>\n                    <ForeName>Andrea</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Turrini</LastName>\n                    <ForeName>Mauro</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Hematology, Division of Medicine, Valduce Hospital, Como, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pistocchi</LastName>\n                    <ForeName>Anna</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Biotechnology and Translational Medicine, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Neri</LastName>\n                    <ForeName>Antonino</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, Universit\xc3\xa0 degli Studi di Milano, Milano.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Hematology, Fondazione IRCCS C\xc3\xa0 Granda, Ospedale Maggiore Policlinico, Milano.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chiaramonte</LastName>\n                    <ForeName>Raffaella</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health Sciences, Universit\xc3\xa0 degli Studi di Milano, Milano raffaella.chiaramonte@unimi.it michela.colombo@ndcls.ox.ac.uk.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>03</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Italy</Country>\n            <MedlineTA>Haematologica</MedlineTA>\n            <NlmUniqueID>0417435</NlmUniqueID>\n            <ISSNLinking>0390-6078</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31582544</ArticleId>\n            <ArticleId IdType="pii">haematol.2019.221077</ArticleId>\n            <ArticleId IdType="doi">10.3324/haematol.2019.221077</ArticleId>\n            <ArticleId IdType="pmc">PMC7327642</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Leukemia. 2013 Jul;27(7):1558-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23354012</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2004 Dec 1;104(12):3697-704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15292061</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Apr 19;7(16):21713-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26967055</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Dis Primers. 2017 Jul 20;3:17046</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28726797</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pathol Res Pract. 2018 Sep;214(9):1388-1394</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30098829</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Hematol. 2009 Jan;37(1):78-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19013005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drugs. 2018 Jan;78(1):19-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29188449</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2011 Jul 14;118(2):380-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21602525</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Steroid Biochem Mol Biol. 2015 Mar;147:24-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25448748</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Hematol. 2010 Nov;89(11):1133-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20532504</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Pathol. 2010 Dec;41(12):1702-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20800871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neoplasia. 2019 Jan;21(1):93-105</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30529074</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2004 Mar 26;279(13):12876-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14709552</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2011 Dec 15;118(25):6506-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21979940</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2011 Sep 1;308(1):1-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21652011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2012 Apr 1;3(4):879-884</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22741011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20778-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22143792</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2007 Nov 15;110(10):3557-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17690257</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Sep 29;6(29):26826-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26308486</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunol Rev. 2015 Jan;263(1):160-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25510276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Aug 30;7(35):56013-56029</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27463014</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Target Oncol. 2018 Jun;13(3):257-267</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29520705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biomed Biotechnol. 2012;2012:157496</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23093834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2017 Nov 3;12(11):e0182640</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29099834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2015 Nov 27;467(4):717-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26494298</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2014 Nov 15;5(21):10393-406</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25257302</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genes Chromosomes Cancer. 2015 Aug;54(8):516-526</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26052821</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2004 May 1;103(9):3511-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14726396</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Immunol. 2018 Aug 14;9:1823</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30154786</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2005 Feb 28;219(1):113-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15694671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leukemia. 2013 Apr;27(5):1009-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23307030</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood Cancer J. 2012 May;2(5):e73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22829975</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 2005 Jun;166(6):1817-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15920166</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2016 Jan 15;76(2):463-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26744527</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 May 15;69(10):4380-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19417136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Biochem Cell Biol. 2015 Sep;66:134-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26235278</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Pharm Des. 2017;23(1):108-134</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27719637</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2016 Jul 14;128(2):249-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27207793</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leukemia. 2007 May;21(5):1070-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17315024</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2017 Oct;179(1):36-49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28670693</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem J. 2013 Apr 1;451(1):123-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23323858</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Pharmacol. 2019 Feb 27;10:145</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30873026</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2012 Nov 30;428(4):518-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23111325</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Development. 1997 Oct;124(20):4133-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9374409</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Sci. 2004 Nov;82(1):341-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15319485</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2009 Apr 30;113(18):4341-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19139079</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood Cancer J. 2017 Dec 15;7(12):650</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29242532</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2008 Feb 15;111(4):2220-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18039953</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2004 May 1;103(9):3503-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14670925</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2019 Feb 1;79(3):639-649</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30563887</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Oncol. 2014 Sep 25;4:254</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25309874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'